Mackenzie Financial’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
22,457
-241
| -1% | -$13.3K | ﹤0.01% | 957 |
|
|
2025
Q1 | $1.1M | Buy |
22,698
+1,349
| +6% | +$65.2K | ﹤0.01% | 953 |
|
|
2024
Q4 | $824K | Buy |
21,349
+13,575
| +175% | +$524K | ﹤0.01% | 993 |
|
|
2024
Q3 | $350K | Buy |
+7,774
| New | +$350K | ﹤0.01% | 1125 |
|
|
2023
Q3 | – | Sell |
-12,745
| Closed | -$284K | – | 1566 |
|
|
2023
Q2 | $284K | Sell |
12,745
-14,759
| -54% | -$329K | ﹤0.01% | 1183 |
|
|
2023
Q1 | $633K | Buy |
+27,504
| New | +$633K | ﹤0.01% | 957 |
|